Grace Therapeutics, Inc. (GRCE)

NASDAQ: GRCE · Real-Time Price · USD

Compare

3.650

+0.010 (0.27%)

At close: Jan 16, 2026, 4:00 PM EST

3.600

-0.050 (-1.37%)

After-hours: Jan 16, 2026, 7:34 PM EST

Grace Therapeutics Income Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2016 - 2020
Revenue	-	-	-	-	-	0.2	Upgrade
Cost of Revenue	-	-	-	-	-	0.08	Upgrade
Gross Profit	-	-	-	-	-	0.12	Upgrade
Selling, General & Admin	7.16	7.17	6.68	8.28	6.58	6.66	Upgrade
Research & Development	5.35	9.51	4.59	9.93	5.56	4.17	Upgrade
Operating Expenses	12.5	16.68	11.28	18.21	12.14	10.84	Upgrade
Operating Income	-12.5	-16.68	-11.28	-18.21	-12.14	-10.72	Upgrade
Interest Expense	-	-	-	-	-	-0.26	Upgrade
Interest & Investment Income	0.68	0.71	0.91	0.25	0.08	0.11	Upgrade
Currency Exchange Gain (Loss)	-0.02	-0.02	-0.02	-0.07	-0.3	-0.68	Upgrade
Other Non Operating Income (Expenses)	2.4	3.22	-2.73	0.01	5.34	-2.43	Upgrade
EBT Excluding Unusual Items	-9.44	-12.77	-13.11	-18.02	-7.02	-13.98	Upgrade
Merger & Restructuring Charges	-	-	-1.49	-33.51	-3.2	-	Upgrade
Asset Writedown	-0	-0	-0.09	-0.44	-0.25	-5.7	Upgrade
Pretax Income	-9.44	-12.77	-14.69	-51.97	-10.47	-19.68	Upgrade
Income Tax Expense	-1.62	-3.2	-1.83	-9.54	-0.65	-	Upgrade
Net Income	-7.82	-9.57	-12.85	-42.43	-9.82	-19.68	Upgrade
Net Income to Common	-7.82	-9.57	-12.85	-42.43	-9.82	-19.68	Upgrade
Shares Outstanding (Basic)	14	12	10	7	6	2	Upgrade
Shares Outstanding (Diluted)	14	12	10	7	6	2	Upgrade
Shares Change (YoY)	23.94%	26.85%	28.16%	21.09%	148.46%	40.25%	Upgrade
EPS (Basic)	-0.55	-0.79	-1.35	-5.71	-1.60	-7.96	Upgrade
EPS (Diluted)	-0.55	-0.79	-1.35	-5.71	-1.60	-7.96	Upgrade
Free Cash Flow	-12.01	-14.9	-12.36	-15.93	-17.23	-14.39	Upgrade
Free Cash Flow Per Share	-0.84	-1.23	-1.30	-2.14	-2.81	-5.82	Upgrade
Gross Margin	-	-	-	-	-	61.22%	Upgrade
Operating Margin	-	-	-	-	-	-5467.35%	Upgrade
Profit Margin	-	-	-	-	-	-10039.80%	Upgrade
Free Cash Flow Margin	-	-	-	-	-	-7340.82%	Upgrade
EBITDA	-12.5	-16.67	-11.27	-18.08	-11.22	-9.79	Upgrade
D&A For EBITDA	0.01	0.01	0.01	0.12	0.92	0.92	Upgrade
EBIT	-12.5	-16.68	-11.28	-18.21	-12.14	-10.72	Upgrade

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q